These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3406212)

  • 41. The dexamethasone suppression test in psychotic disorders.
    Arana GW; Barreira PJ; Cohen BM; Lipinski JF; Fogelson D
    Am J Psychiatry; 1983 Nov; 140(11):1521-3. PubMed ID: 6625007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Dexamethasone test in the diagnosis of depressions in childhood and adolescence (a review)].
    Belkin AI; Khaĭsman AE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):140-4. PubMed ID: 3284259
    [No Abstract]   [Full Text] [Related]  

  • 43. [The dexamethasone suppression test and TRH stimulation test in endogenous depressives, schizophrenics, and normal volunteers].
    Ho SL; Lu RB; Ferng HK; Lin TY
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Apr; 41(4):271-80. PubMed ID: 3141027
    [No Abstract]   [Full Text] [Related]  

  • 44. Positive and negative symptoms in schizophrenia and the Dexamethasone Suppression Test.
    Tandon R; Silk KR; Greden JF; Goodson J; Hariharan M; Meador-Woodruff JH; Kronfol Z
    Biol Psychiatry; 1989 Mar; 25(6):788-92. PubMed ID: 2629711
    [No Abstract]   [Full Text] [Related]  

  • 45. [Plasma kynurenine levels and the dexamethasone test in patients with endogenous anxiety disorders and depression].
    Orlikov AB; Prakh'e IB; Ryzhov IV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(10):83-5. PubMed ID: 1963008
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The dexamethasone suppression test and residual schizophrenia.
    Harris VJ
    Am J Psychiatry; 1985 May; 142(5):659-60. PubMed ID: 3985211
    [No Abstract]   [Full Text] [Related]  

  • 47. Dexamethasone suppression test in Brazil.
    Kerr F; Carlini EA; Sonenreich C
    Biol Psychiatry; 1990 Mar; 27(6):678-80. PubMed ID: 2322630
    [No Abstract]   [Full Text] [Related]  

  • 48. Multiendocrine assessment in the dexamethasone suppression test.
    Risch SC; Janowsky DS; Judd LL; Gillin C; Mott M; Rausch JL; Huey LY
    Psychopharmacol Bull; 1986; 22(3):913-6. PubMed ID: 3025914
    [No Abstract]   [Full Text] [Related]  

  • 49. The dexamethasone suppression test in depression.
    Dam H; Mellerup ET; Rafaelsen OJ
    J Affect Disord; 1985; 8(1):95-103. PubMed ID: 3156917
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients.
    Doran AR; Rubinow DR; Roy A; Pickar D
    Arch Gen Psychiatry; 1986 Apr; 43(4):365-9. PubMed ID: 2869743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dexamethasone suppression test and depressive symptoms in schizophrenics and endogenous depressed patients.
    Perényi A; Frecska E; Rihmer Z; Arató M
    Pharmacopsychiatry; 1987 Mar; 20(2):48-50. PubMed ID: 3588661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dexamethasone nonsuppression in chronic schizophrenia.
    Whiteford HA; Riney SJ; Savala RA; Csernansky JG
    Acta Psychiatr Scand; 1988 Jan; 77(1):58-62. PubMed ID: 3273153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Caffeine-induced escape from dexamethasone suppression.
    Uhde TW; Bierer LM; Post RM
    Arch Gen Psychiatry; 1985 Jul; 42(7):737-8. PubMed ID: 3893356
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of diagnosis and age on the DST: a metaanalytic approach.
    Sharma RP; Pandey GN; Janicak PG; Peterson J; Comaty JE; Davis JM
    Biol Psychiatry; 1988 Sep; 24(5):555-68. PubMed ID: 3167144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dexamethasone suppression test in schizophrenia. A study and review.
    Asnis GM; Eisenberg J; Lemus CZ; Halbreich U
    Neuropsychobiology; 1986; 15(3-4):109-13. PubMed ID: 3785640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dexamethasone concentrations and the dexamethasone suppression test in psychiatric disorders.
    Morris H; Carr V; Gilliland J; Hooper M
    Br J Psychiatry; 1986 Jan; 148():66-9. PubMed ID: 3955321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The dexamethasone suppression test: clinical applications.
    Brown WA
    Psychosomatics; 1981 Nov; 22(11):951-5. PubMed ID: 7313051
    [No Abstract]   [Full Text] [Related]  

  • 58. Preliminary report on the dexamethasone suppression test in adolescents.
    Robbins DR; Alessi NE; Yanchyshyn GW; Colfer MV
    Am J Psychiatry; 1982 Jul; 139(7):942-3. PubMed ID: 7091415
    [No Abstract]   [Full Text] [Related]  

  • 59. [The niacin test in schizophrenia].
    Weterle R; Rybakowski J
    Psychiatr Pol; 1990; 24(2):116-20. PubMed ID: 2084715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Use of biological markers in depression in the elderly].
    Meco G; Capriani C; Pasqualoni V; Bonifati V; Vanacore N
    Minerva Psichiatr; 1988; 29(4):175-8. PubMed ID: 3249554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.